HM Medical Clinic

Take Clomid is contraindicated in the presence of cysts in the ovaries, liver and kidney failure, the presence of pituitary tumors or genital organs hecticlifehealthygirl.com Product description posted on this page is a supplement and a simplified version of the official version of the annotations to the drug.

Cialis ne doit pas être prise à tous. Il est important que cialis en ligne est prescrit par un médecin, bien se familiariser avec les antécédents médicaux du patient. Ich habe Probleme mit schnellen Montage. Lesen Sie Testberichte Nahm wie cialis rezeptfrei 30 Minuten vor dem Sex, ohne Erfolg. Beginn der Arbeiten nach 4 Stunden, links ein Freund ein trauriges Ja, und Schwanz in sich selbst nicht ausstehen, wenn es keinen Wunsch ist.

Ipaustralia.gov.au

Vol 19 , No. 341 September 2005 AUSTRALIAN OFFICIAL JOURNAL The Australian Official Journal of Patents is part of the Official Journal issued by the Commissioner of Patents for the purposes of the Patents Act 1990, the Trade Marks Act 1995 and Designs Act 2003.
AUSTRALIAN OFFICIAL JOURNAL OF PATENTS 1 September 2005 General Information & Notices
Amendments, Section 104
Applications for Amendment . . . . . . . . . . . . . . . . . . . 550
Applications For Amendment Withdrawn . . . . . . . . . . . . . . . 550
Amendments Made
Applications Lapsed, Refused Or Withdrawn
Patents Ceased or Expired . . . . . . . . . . . . . . . . . . . 549

Assignments before Grant, Section 113 . . . . . . . . . . . . . 549
Assignments Registered . . . . . . . . . . . . . . . . . . . 558
Extensions of Term of Standard Patents, Section 70 . . . . . . . . 559
Extensions of Time, Section 223 . . . . . . . . . . . . . . . . 549
Licences Registered . . . . . . . . . . . . . . . . . . . . . 559
Mortgages Registered . . . . . . . . . . . . . . . . . . . . . 559
Opposition Proceedings . . . . . . . . . . . . . . . . . . . . 557
Specifications Republished . . . . . . . . . . . . . . . . . . 559
General Information EDITORIAL ENQUIRIES FREEDOM OF INFORMATION ACT All enquiries about official notices and general information in the What does it do? Journal should be directed to IP Australia, Gives you right to obtain information held by (ABN No 38 113 072 755), Commonwealth Ministers, Departments and most statutory PO Box 200 Woden ACT 2606 bodies (these bodies are called agencies under the Act). Requires Commonwealth Government agencies to make available to members of the public: Telephone 1300 651 010 Information about agencies, their functions and (International Callers +61 2 6283 2999 ) Fax 02 6283 7999 Information about rules and practices which are E-mail assist@ipaustralia.gov.au used in making decisions which affect you. Gives you a legal right to: CONTACT INFORMATION See non exempt documents held by agencies, and Customer Service Network appeal against a decision not to grant access to a Telephone 1300 651 010 , Fax: 02 6283 7999 E-mail: assist@ipaustralia.gov.au Customers can contact the Customer Service Network by What documents can you see? telephone or by e-mail. Telephones are staffed between 9am and The Act gives you a right to see documents lodged on or 5pm each working day. after 1 December 1977, or earlier if you need them to understand another document you have already. Customers should contact the Customer Service Network for Documents include files, reports, computer printouts, maps, information about: plans, photographs, tape recordings, films or videotapes. Documents which are available for purchase under the All Patent Matters including PCT and Innovation Patents Act 1990, the Trade Marks Act 1995 or Designs Act 2003 are not available under the Freedom of Information All Trade Mark Matters. Act (Section 12 refers). All Design Matters. How do you apply? Professional Standards Board for Patent and Trade Mark Requests for access to documents must Ph: 02 6283 2345 Fax: 02 6283 1048 Provide sufficient information so as to enable identification ORDERING PATENT DOCUMENTS of the documents requested When ordering copies of Australian patent specifications, or Specify an address in Australia where notices can be sent abstracts and abridgments notified as open to public inspection on or after 26 October 1978, or as accepted on or after 16 Be accompanied by the application fee (currently $30.00) or November 1978, the documents should be referred to by specify an IP Australia account to which the charges will be application numbers only, preceded by letters AU-A or AU-B Requests for documents should be addressed to IP Australia, PO Box 200 Woden, ACT 2606, or Faxed to 02 6283 7999 REQUESTS FOR INFORMATION UNDER SECTION 194 ( C ) A request for information under Section 194 ( C ) of the Patents Act 1990 should be made in the approved form and be accompanied by the prescribed fee. The request should be as detailed as possible. INFORMATION FROM REGISTERS All requests for information from Register of Patents, Trade Marks or Designs, should be made in writing and accompanied by the prescribed fee. The Registers are located in Canberra and may be examined free of charge. COUNTRY CODES For a listing of country codes used by IP Australia please refer to the Official Journals dated 7 November 1996. ABBREVIATIONS IN JOURNAL Standard abbreviations are used in the name of companies and firms. Enquiries concerning the precise name should be directed to the Customer Service Network. DECISIONS OF THE COMMISSIONER OF PATENTS AND LIST OF STATE OFFICES REGISTRAR OF TRADE MARKS AND DESIGNS IP Australia State Offices are located in the Australian Capitals at All decisions of the Commissioner and Registrars are the addresses given below. Requests for information may be available free of charge from AUSTLII's website obtained by calling at, phoning or writing to these offices or IP www.austlii.edu.au Australia, Canberra. Copies of all written Patent and Design decisions are available (except if they would not be available under the provisions of the Australian Capital Territory Freedom of Information legislation, e.g. if they would effectively disclose matter from documents that are not open to public inspection) on request for a cost of $AU 25. They are also PHILLIP ACT 2606 available for inspection in indexed volume series, dating from 1 (PO Box 200, WODEN ACT 2606) January 1987, in the Office library, Canberra. Ph: 1300 651 010 Copies of Trade Mark decisions may be accessed via IP Australia's Fax: (02) 6283 7999 website www.ipaustralia.gov.au Copies of the taped record of Patent and Design hearings are available (with the same exception as above) on request. When a written decision is issued the fact of the decision 45 Clarence Street plus a brief head note will be published in the Official Notices section of the next available Patents, Trade Marks or Ph: 1300 651 010 Designs Journal. Fax: (02) 9249 5807 HEARINGS BEFORE THE COMMISSIONER OF PATENTS AND THE REGISTRARS OF TRADE MARKS AND DESIGNS Hearings before the Commissioner of Patents and the Registrars of Trade Marks and Designs will be set down in Melbourne, 565 Bourke Street Sydney, Adelaide, Perth and Brisbane during the periods MELBOURNE VIC 3000 indicated below. Ph: 1300 651 010 Fax (03) 9612 9807 Patent Hearings Sessions 2005 Western Australia East Point Plaza 233 Adelaide Terrace Ph: 1300 651 010 Fax: (08) 9220 8907 1 – 2 September Grant Thornton House Note: Expert matters will have priority over other matters for 102 Adelaide Street allocation of a hearing in these sessions. BRISBANE QLD 4000 Ph: 1300 651 010 Fax: (07) 3007 1107 Designs and Trade Marks Hearings Sessions 2005 14 – 18 February Origin Energy House 1 King William Street ADELAIDE SA 5000 Ph: 1300 651 010 Fax: (08) 8239 4507 15 – 16 August 18 – 19 August 27 Elizabeth Street 22 – 23 August Ph: 11300 651 010 Fax: (03) 6235 6307 Persons who desire matters to be set down for hearing in Melbourne, Sydney, Adelaide, Perth or Brisbane must give at least one month's notice of their intention to be heard. If such notice is not given, it may be that there would be insufficient time to allow for the execution of official procedures associated with the listing of hearings, and as a result, the matter involved might not be listed. Subject to the convenience of this Office, hearings will be set down in Canberra at any time suitable to the parties. GUIDE TO THE USE OF THIS JOURNAL The Australian Official Journal of Patents (AOJP) reports on all the major events and actions which take place during the life cycle of an Australian patent and provides certain details of these actions as they relate to the patent or patent application involved. This guide sets out to teach the reader how to use the journal to access this information. While there are many possible actions in the life of a patent, the majority of actions reported relate to the following events, which are the main stages in the progression of a patent application to a sealed patent: (i) FILING – This is the act of making an application. When the application is first filed certain details are published. (ii) OPEN-TO-PUBLIC-INSPECTION (OPI) – Approximately 18 months after first filing of an Australian or a corresponding foreign application, certain application documents, including the complete specification, become available to the public (Open-to-Public-Inspection or "OPI"). Relevant application details are published. In addition, an Abstracts Supplement to the AOJP contains abstracts of the inventive content of the OPI (iii) ACCEPTANCE - This is the Commissioner's acceptance of a patent application. Once the Commissioner has accepted a patent application, certain details of the application are published in the AOJP. In addition, an Abridgments Supplement contains an abridgment (usually the broadest accepted claim and relevant drawing where appropriate) for each accepted application. Notice of opposition may be filed within three months of advertisement of acceptance. (iv) OPPOSITION – If an opposition action is commenced against the grant of the patent, the six-figure acceptance number and the name of the opponent are published. (v) SEALING – Most accepted applications are not opposed. These proceed to sealing and become granted patents. Of the few that are opposed (less than 1%) most of these, after resolution of the opposition, proceed to sealing and become granted patents. Sealed patents are simply listed in order of their six-figure acceptance number. In addition to the actions related to these stages, other actions reported include: assignments, lapsing or withdrawal of applications and ceasing or expiry of patents, voluntary amendments, extensions of time for certain actions and registration of licences. How To Identify Information Using "INID" Numbers Patents are published in many different languages. As a result, finding the information that you want (eg the filing date) on a patent document or in a journal can be quite difficult. There is an international system operating, however, which codifies this information in an unambiguous way, by assigning a specific number to each piece of information about the history of a patent. These numbers are called the international agreed Numbers for the identification of Data or INID numbers. These numbers appear on all published patents and abstracts and are used throughout this journal to identify particular items of information. For example, the data on which a document is filed has the INID number (22), while the name of the applicant has the INID number (71). These numbers are always expressed in parentheses and always immediately precede the information to which they relate. For means that the filing date of the document which contains this reference is 12 October 1991. Learning the INID numbers for the information you want will help you find it quickly and easily. A complete list of the INID numbers and the items to which they relate is provided at the end of this Guide. How Australia Patent Documents are Numbered Patent applications in Australia are assigned numbers at various stages in their processing. Each Australian application which proceeds to acceptance will have at least two (and sometimes more) different numbers during its life. When searching for information and ordering documents it is vital that you understand the numbering systems. 1. Provisional Applications are given a number with two characters and four numbers A provisional application number is identified by the INID number (21). 2. Complete Applications are given a five-figure application number followed by the last two digits of the year of filing There are prefixes applied to this number which indicate whether the application has been accepted: A document corresponding to an unaccepted application has the prefix, AU-A; e.g. AU-A-12345/93. A document corresponding to an accepted application carries the prefix AU-B; e.g. AU-B-12345/93. Users need to be aware that an accepted document may differ from the corresponding unaccepted document. amendment may occur between first publication (OPI) and second publication (acceptance). A five-figure application number is identified by the INID numbers (11) or (21). 3. When a patent application is accepted it is given a six-figure document number in addition to the five-figure application number This is the number you must use to keep track of the application in the AOJP from now on. It is identified by the INID number (10). NOTE: When ordering any patent document from us, whether accepted or not, please quote the five-figure application number preceded by the appropriate prefix. Arrangement of Information in the Journal For each of the categories (i) Provisional Applications Filed, (ii) Complete Applications Filed (iii) Applications Open to Public Inspection, and (iv) Applications Accepted The Journal lists the information published in that category in an alphabetical Name Index list based on the name of the applicant. These indices are useful if you wish to find information about applications made by a particular applicant. In addition to the Name Index there is provided, for each of these categories, a Numerical Index. This index lists the applications either in order of their five-figure Application Numbers, in the case of complete applications filed and applications OPI, or in order of their six-figure Document Number in the case of accepted applications. It provides, for each number, the name of the applicant. These indices are useful if you wish to track the progress of a particular patent application. There are also IPC indices provided for applications which are OPI and for applications which have been accepted. IPC stands for International Patent Classification. Each IPC "mark" is an alpha-numerical representation of a particular area of technology. These indices are in order of IPC mark, and within each mark provide either the five-figure application numbers of the applications which are now OPI or the six-figure numbers of the cases now accepted. These indices are useful if you wish to check on patent activity in a particular technology. Using the Indices 1. To Find Patent Information If You Know the Name of the Applicant. Use the Name Indices. They wil give you the following information identified by their INID number: ITEM INID A) Provisional applications filed – Name Index B) Complete applications filed – Name Index The name of the applicant The name of the applicant The Provisional application number (21) number assigned to the application The date of filing The date of filing The title of the invention Title of the invention Number of priority document(s) if any Date(s) of filing of priority documents Country in which priority document filed PCT application number (86) C ) Applications open to public inspection – Name D) Applications accepted – Name Index The name of the applicant The name of the applicant The number of the document The number of the document The number assigned to the application The number of the accepted document The date of filing The number assigned to the application The classification marks (51) Priority document number(s) (31) classification marks (51) Date of filing of priority document(s) PCT publication number (87) Country in which priority document filed Priority document number(s) (31) Publication date of unexamined document Date of filing of priority document(s) Inventors names if known Country in which priority document filed Patent Attorneys (74) date of unexamined document Related by addition Publication date of examined document Related by division Publication date of granted document Patent Attorneys (74) You will notice at each stage of following an application through that all applications are in alphabetical order of Applicant, not inventor. 2. To Find Information About a Patent Application If You Know Its Number. Use the appropriate numerical index. This will give you the name of the applicant from the number. You will then need to use the appropriate Name Index as above to find out other information about the Patent Application you are interested in. The following Numerical Indices are available: A) Provisional Applications filed. Complete Applications filed. Open to Public Inspection. Accepted (note that this uses six-figure document numbers rather than five-figure application numbers). 3. To Find Information About Patent Documents in the Area of Technology in which You are Interested if You Know the International Patent Classification Mark for that Area. All patent applications are classified according to their subject matter using the International Patent Classification ( IPC ). Although the system is very detailed and covers all technologies, knowledge of the IPC marks of the technologies you are interested in will allow you to find patent documents in these technologies quite easily. To identify the IPC marks of technologies you are interested in, you can inspect relevant documentation in any of IP Australia's state offices. The indices to use are OPI – IPC Index Accepted – IPC Index. These indices give you the numbers of the applications which are either OPI or Accepted and are listed in order of their IPC marks. Once you have the numbers of the documents that interest you, consult the relevant Number Index (see 2. above) to find the applicant's name, and then the Name Index (see 1. above) to find out the details of that application. INID NUMBERS in use on Australian Patent Documents INID is an acronym for ‘ Internationally agreed Numbers for the Identification of Data '. (10) Document Identification (11) Number of the document (12) Plain language designation of the kind of document. (19) WIPO country code, or other identification, of the country publishing the document. (20) Document filing data (21) The number(s) assigned to the application(s) (22) Date(s) of filing application(s) (23) Other date(s) of filing, including exhibition filing date of filing complete specification following provisional specification. (24) Date from which industrial property rights may have effect. (30) Priority date (31) Number(s) assigned to priority application(s) (32) Date(s) of filing priority application(s) (33) Country (countries) in which the priority application(s) was (were) filed. (40) Date(s) of making available to the public (43) Date of publication by printing or similar process of an unexamined document, on which no grant has taken place on or before the said date. (44) Date of publication by printing or similar process of an examined document, on which no grant has taken place on or before the said date. (45) Date of publication by printing or similar process of a document, on which grant has taken place on or before the said date. (50) Technical Information (51) International Patent Classification. (52) Domestic or national classification. (54) Title of invention. (56) List of prior art documents, if separate from descriptive text. (57) Abstract or claim. (60) Reference(s) to other legally related domestic document(s) (60) Related by cognate(s). (61) Related by addition(s) (62) Related by division(s). (70) Identification of parties concerned with document (70) Name(s) of nominated person (71) Name(s) of applicant(s). (72) Name(s) of inventor(s) if known to be such. (74) Name(s) of attorney(s) or agent(s). (75) Name(s) of inventor(s) who is (are) also applicant(s) (80) Identification of data related to International Conventions other than the Paris Convention (86) PCT Application Number. (87) PCT Publication Number. (1) Australian patent documents published on or after 26 October 1978 should be referred to by the application number preceded by the AU-A or AU-B. AU-A = Pre-examination AU-B = Post-examination (2) The classification used is the International Patent Classification and is identified by the INID code (51). Further editions of the classification are identified as (51)2, (51)3, (51)4 and (51)5. (3) INID code 74 provides for the name of patent attorney, or firm of attorneys, prosecuting an application. (4) No provision is made for addresses for service. Addresses for service of applicants not represented by an independent attorney or firm are viewable at www.ipaustralia.gov.au and on sale at the IP Australia State Offices. AUSTRALIAN OFFICIAL JOURNAL OF PATENTS
1 September 2005
Patents Hearings Sessions
For many years, patent proceedings have been set for hearing on the basis that they should be heard as soon as
possible after the completion of the evidentiary stages and at a time and location that is convenient to the parties.
To this end hearings not set in Canberra are now routinely held out of ‘session' and proceed on the basis that the
parties share the costs of the hearing officer travelling to the desired location.
This, with the ease of interstate travel in modern times and the availability of telephone and video conferencing,
has led to a significant decrease in the number of patent hearings held in session. The Commissioner has also
been aware that session hearings have resulted in unnecessary procedural delays and costs, particularly in
instances where parties have caused hearings to be cancelled at short notice. Therefore, the Commissioner
believes that the setting of interstate hearing sessions is no longer necessary or justified.
As a consequence, for patent matters, there will be NO hearings sessions set for 2006 or subsequent years. The
Commissioner will however continue her practice of having hearings outside of Canberra at a convenient time
where the parties bear the travel costs of the hearing officer and will continue to provide the option of telephone
and video conferencing.
When a matter requires hearing, the various options available are set out in the document ‘Options for Hearings'
available on IP Australia's website at:

Queries:
Deputy Commissioner of Patents (OH&L) Contact: IP
www.ipaustralia.gov.au AUSTRALIAN OFFICIAL JOURNAL OF PATENTS
1 September 2005
ABSTRACTS OF DECISIONS
DECISION OF A DELEGATE OF THE COMMISSIONER OF PATENTS
(Corrected Version)

Application :
720095 in the name of Syngenta Participations AG
Process for the control of weeds Opposition to the grant of a patent by Monsanto Co.
Decision
Issued 15 August 2005. Abstract
The opposition succeeds on the basis of section 40, but fails on the other grounds. Full description: The specification describes the invention in terms that leave the reader without guidance of where success is likely, or even where success is possible. As such, the specification clearly fails to disclose a manner of carrying out the invention, and consequently does not fully describe the invention. Novelty: Actual or potential synergy is a feature of the claims. The claims are novel because the citations do not teach the presence of synergy between the components. Inventive step: The evidence shows that people in the art knew how to carry out the optimisation of herbicide compositions, but would not have been able to do this in relation to herbicide-resistant plants due to lack of access to modified plants. It follows that the optimisation of compositions for such plants could not have been a matter of routine as a practical matter. Consequently an inventive step exists. AUSTRALIAN OFFICIAL JOURNAL OF PATENTS 1 September 2005 Proceedings under the Patents Act 1990
Assignments before Grant, Section 113 - cont'd
Applications Lapsed, Refused Or Withdrawn
Patents Ceased or Expired

Reference to the application numbers must include the year of the 43874 Xogen Power Inc. The application has been assigned to application of the patent, which is shown preceding the numbers.
Xogen Technologies Inc.
The codes next to each number have the following meanings: Application Lapsed Section 142(2)(a) S 47(C) Application Lapsed Section 142(2)(b) Application Lapsed Section 142(2)(c) S 52B(3) Application Lapsed Section 142(2)(d) S 47D(1) Application Lapsed Section 142(2)(e) S 53 Application Lapsed Section 142(2)(f)/Reg 8.3(3) Extensions of Time, Section 223
Application Lapsed Reg. 3.2(5)(a) R 7B(3) Application Lapsed Reg. 3.4(6) Application Lapsed Section 142(3) Application Lapsed Section 142(4)(b) Application Lapsed Section 148(1)(c) Notice of opposition under Section 223(6) to the undermentioned Application Withdrawn Section 141(1)/Reg 8.3(2) S 37 application(s) for an extension of time may be lodged at the Patent Application Withdrawn Section 141(2)/Reg 8.3(2) Office within the prescribed time.
Patent Ceased Section 143(a), or Expired Patent Ceased Section 143(b) Application refused Application Lapsed Regulation 22.2 56540 Good Health Products Ltd. An application to extend the
Applications on which examination has not been requested or time from 20 Jul 2005 to 20 Nov 2005 in which to obtain acceptance has been lodged. Address for service in Australia - A J Park & Applications on which a direction to request examination has Son PO Box 949 Wellington 6001 NEW ZEALAND Applications on which examination has been requested or on 617439 Kyorin Pharmaceutical Co., Ltd. An application to extend
which an examination report has been issued the time from 1 Mar 2004 to 1 Jun 2005 in which to pay a renewal Applications which have been accepted or advertised fee has been lodged . Address for service in Australia - Griffith accepted, (including applications which have also been Hack GPO Box 4164 SYDNEY NSW 2001 advertised 'Not Sealed') 660981 Biogen Idec MA Inc. An application to extend the time from
Applications Not Open to Public Inspection 7 Nov 2004 to 19 Jul 2005 in which to to extend the term of thepatent . Address for service in Australia - Cullen & Co GPO Box 1074 BRISBANE QLD 4001 704055 Inpro Companies, Inc. An application to extend the time
from 9 May 2004 to 9 Jun 2005 in which to pay a renewal fee hasbeen lodged . Address for service in Australia - SPRUSON & FERGUSON GPO Box 3898 SYDNEY NSW 2001 726890 Massachusetts Institute of Technology; University
Technology Corp. and General Hospital Corp., The
An application
Assignments before Grant, Section 113
to extend the time from 22 May 2003 to 22 Nov 2004 in which to paya renewal fee has been lodged . Address for service in Australia -Davies Collison Cave GPO Box 3876 SYDNEY NSW 2001 781275 Merck Patent GmbH; Arnd Petersen The application has
been assigned to Merck Patent GmbH
Applications Allowed - Section 223(2)
781615 Rockwell Electronic Commerce Corporation The
application has been assigned to Rockwell Electronic Commerce
605057 Massachusetts Institute of Technology The time in which
to pay a renewal fee has been extended to 25 Jun 2005 . Addressfor service in Australia - Blake Dawson Waldron Level 39 101 Collins 782128 Rockwell Electronic Commerce Corporation The Street MELBOURNE VIC 3000 application has been assigned to Rockwell Electronic Commerce
Technologies, LLC

652634 Raider Electronics Pty Ltd. The time in which to pay a
renewal fee has been extended to 20 Apr 2005 . Address for
782401 Ontogen Corporation The application has been assigned service in Australia - Griffith Hack 256 Adelaide Terrace PERTH WA to Taiji Biomedical, Inc.
782696 Thermo-Med 2000 KFT The application has been 750079 Kukainis, I.L. and O'Brien, P.J. The time in which to pay a
assigned to INVATEC S.r.l.
renewal fee has been extended to 29 May 2005 . Address for AUSTRALIAN OFFICIAL JOURNAL OF PATENTS 1 September 2005 Extensions of Time, Section 223 -cont'd
Applications for Amendment -cont'd
service in Australia - PHILLIPS ORMONDE & FITZPATRICK 367 773208 Screening equipment Weatherford Australia Pty. Ltd. The
Collins Street MELBOURNE VIC 3000 nature of the proposed amendment is as shown in the statement(s)filed 14 Jun 2005. Address for service in Australia - F B Rice & CoLevel 23 44 Market Street SYDNEY NSW 2000 757438 Ceebron Pty. Ltd. The time in which to provide search
results under S45(3) has been extended to 8 Apr 2005 . Address for
service in Australia - Shelston IP Level 21 60 Margaret Street
778208 GRF-containing lyophilized pharmaceutical compositions Applied Research Systems ARS Holding N.V. The nature of the
proposed amendment is as shown in the statement(s) filed
17 Mar 2005. Address for service in Australia - Griffith Hack GPO
Box 1285K MELBOURNE VIC 3001
Amendments, Section 104
779483 Composite material Lucite International UK Ltd. The
nature of the proposed amendment is as shown in the statement(s)
Applications for Amendment
filed 28 Jul 2005. Address for service in Australia - Griffith HackGPO Box 4164 SYDNEY NSW 2001 A person interested in opposing the allowance of the amendmentmay, at any time within three months from the date of this journal, 782058 Gamma-herpesvirus DNA and methods of use Immerge
give notice at the Patent Office using the approved form BioTherapeutics AG The nature of the proposed amendment is as
accompanied by the prescribed fee.
shown in the statement(s) filed 29 Jul 2005. Address for service inAustralia - SPRUSON & FERGUSON GPO Box 3898 SYDNEY 711144 Materials and methods for management of hyperacute rejection in human xenotransplantation Bresagen Ltd. and St
Vincent's Hospital (Melbourne) Ltd.
The nature of the proposed
Applications For Amendment Withdrawn
amendment is as shown in the statement(s) filed 18 May 2005. Address for service in Australia - PETER MAXWELL &ASSOCIATES PO Box R1466 Royal Exchange SYDNEY NSW 1225 781131 Intec Science, Inc. the amendments dated 22 Jul 2005
have been withdrawn.
729505 Evolving cellular DNA uptake by recursive sequence
recombination Maxygen, Inc. The nature of the proposed
amendment is as shown in the statement(s) filed 24 May 2005. Address for service in Australia - SPRUSON & FERGUSON GPOBox 3898 SYDNEY NSW 2001 717114 Den Norske Stats Oljeselskap A.S The nature of the
amendment is as was notified in the Official Journal dated
745006 C-4''-substituted macrolide derivatives Pfizer Products Inc.
The nature of the proposed amendment is as shown in thestatement(s) filed 4 Aug 2005. Address for service in Australia - 775126 Bayer HealthCare AG The nature of the amendment is as
SPRUSON & FERGUSON GPO Box 3898 SYDNEY NSW 2001 was notified in the Official Journal dated 10 Mar 2005 752486 Shielding assembly Bramwells, H.W. The nature of the
778052 Battelle Memorial Institute The nature of the amendment is
proposed amendment is as shown in the statement(s) filed as was notified in the Official Journal dated 10 Mar 2005 8 Jul 2005. Address for service in Australia - Hugh WilliamBramwells 3 Rose Street Highett Melbourne VIC 3190 Applications Accepted
Name Index

The Nominated Person(s) (INID 70) are listed only if they differ from the Applicant(s) (INID 71). Otherwise only the Applicant(s) are listed.
ADENOVIRUS COMPRISING A NUCLEIC (54) FORMULATION OF SUBSTITUTED
ACID ENCODING AN ANGIOGENIC (71) Aberdeen University; Statens Veterinaere
FACTOR FOR TREATING PULMONARY (51)7 A61K 031/44
(10) 782805
(51)7 C12N 015/12
(31) 9903831
(54) MONOCLONAL ANTIBODY 3F1H10
NEUTRALISING VHSV (VIRAL (31) 99 05272
HAEMORRHAGIC SEPTICAEMIA VIRUS) (72) Brulls, M.
(51)7 C12N 015/13
(74) Freehills Patent & Trade Mark Attorneys
Astrazeneca UK Ltd. see GTC Biotherapeutics,
(72) Adnot, S.; Branellec, D.
(31) PA199901329 (32) 20.09.99
(74) Davies Collison Cave
(44) 01.09.05
(72) Secombes, C.J.; Cunningham, C.; Lorenzen,
(71) Basf Aktiengesellschaft
(71) Aventis Pharma S.A.; Institut National De La
(10) 782843
Sante Et De La Recherche Medicale - (74) PETER MAXWELL & ASSOCIATES
(10) 782833
(71) AstraZeneca AB
(10) 782866
(54) USE OF A RECOMBINANT DEFECTIVE
(51)7 C07D 495/04
AUSTRALIAN OFFICIAL JOURNAL OF PATENTS 1 September 2005 Applications Accepted - Name Index cont'd
(72) Nuss, J.M.; Ramurthy, S.
(74) F.B. Rice & Co.
(72) Chittamuru, R.; Reyes, G.; Farrell, T.P.;
(72) Witschel, M.; Kudis, S.; Langemann, K.;
Vesey, C.F.; Mehra, D.K.; Petereit, H.; (71) Ciba Specialty Chemicals Holding Inc.
Baumann, E.; Deyn, W.v.; Mayer, G.; Misslitz, (10) 782837
U.; Neidlein, U.; Otten, M.; Westphalen, K.; (74) Griffith Hack
(54) OXIME ESTER PHOTOINITIATORS
(74) WATERMARK PATENT & TRADEMARK
(71) Bridge Pharma, Inc.
(51)7 C07C 251/32
(10) 782816
(71) BASF Corp.
(54) OPTICALLY ACTIVE ISOMERS OF
(10) 782800
KETOTIFEN AND THERAPEUTICALLY ACTIVE METABOLITES THEREOF (54) METHODS AND COMPOSITIONS TO
(51)7 A61K 031/445
(72) Kunimoto, K.; Oka, H.; Ohwa, M.; Tanabe, J.;
DEFOLIATE CROP PLANTS AND MINIMIZE Kura, H.; Birbaum, J.
PLANT REGROWTH FOLLOWING (74) Davies Collison Cave
(51)7 A01N 061/00
(71) Computer Controlled Syringe Inc.
(10) 782798
(54) RETRACTABLE NEEDLE DEVICE
(51)7 A61M 005/32
(72) Aberg, A.K.G.; Wright, G.E.; Chen, J.L.;
(72) Evans, J.R.; Evans, R.R.; Harrell, A.L.;
Maioli, A.T.
Stewart, W.W.; King, D.L.
(74) PHILLIPS ORMONDE & FITZPATRICK
(74) WATERMARK PATENT & TRADEMARK
(71) Can-Fite Biopharma Ltd.
(72) Smith, M.T.
(10) 782826
(74) Davies Collison Cave
(71) Bayer Corp.
(10) 782820
(54) PHARMACEUTICAL COMPOSITIONS
(71) D. Swarovski & Co
COMPRISING AN ADENOSINE RECEPTOR (10) 782851
(54) SUBSTITUTED PYRIDINES AND
AGONIST OR ANTAGONIST PYRIDAZINES WITH ANGIOGENESIS (51)7 A61K 031/00
(54) MARKING ELEMENT FOR
INHIBITING ACTIVITY A61K 031/708 A61K 031/7052 (51)7 C07D 401/12
(51)7 E01F 009/053
(31) 131864
(72) Forster, M.
(74) Callinan Lawrie
(72) Fishman, P.
(74) Griffith Hack
(71) Eaton Corp.
Chang, C.P. see Liu, M.
(10) 782844
(72) Dumas, J.P.; Joe, T.K.; Kluender, H.C.E.;
Lee, W.; Nagarathnam, D.; Sibley, R.N.; Su, N.; Boyer, S.J.; Dixon, J.A.
(71) Chemgen Corp.
(54) SOLENOID OPERATED PRESSURE
(74) Davies Collison Cave
(10) 782831
(51)7 F16K 031/06
(54) ENZYME TREATMENT FOR INFECTION
(31) 575625
(71) Beth Israel Deaconess Medical Center;
(51)7 A61K 038/00
Genzyme Corp.
(10) 782807
(72) Koenings, A.G.
(74) F.B. Rice & Co.
(54) SURGICAL RETRACTOR
(51)7 A61B 017/02
(72) Anderson, D.M.; Liu, L.; Hsiao, H.; Fodge,
(71) Electronic Finger Print Technologies Ltd.
(10) 782832
(74) Griffith Hack
Chen, B.D.F. see Liu, M.
(54) METHOD AND APPARATUS FOR
(72) Cohn, W.; Brown, J.H.; Hutchison, D.A.;
AUTHENTICATING FINANCIAL Travers, L.F.; Valerio, M.A.
(74) SPRUSON & FERGUSON
(51)7 G07F 019/00
(71) Chiron Corp.
(10) 782858
(31) 502116
(71) BPSI Holdings, Inc.; Rohm GmbH & Co. KG
(10) 782828
(54) PYRAZINE BASED INHIBITORS OF
GLYCOGEN SYNTHASE KINASE 3 (54) ACRYLIC ENTERIC COATING
(51)7 C07D 241/20
(72) Mitchell, C.; Scholz, K.L.
(51)7 A61K 009/20
(74) PIPERS
AUSTRALIAN OFFICIAL JOURNAL OF PATENTS 1 September 2005 Applications Accepted - Name Index cont'd
Government of the United States of America as
(71) Ethicon, Inc.
represented by the Secretary of The
(54) METHOD OF CONTROLLING PROPPANT
(10) 782806
Department of Health and Human Services, The
FLOWBACK IN A WELL see GTC Biotherapeutics, Inc.
(51)7 E21B 043/267
(54) SCAFFOLD FIXATION DEVICE FOR USE IN
ARTICULAR CARTILAGE REPAIR (51)7 A61F 002/38
(71) Grigg, G.W.
(72) Nguyen, P.D.
(10) 782821
(74) Callinan Lawrie
(54) TREATMENT OF UV INDUCED
(72) Overaker, D.W.
(71) Haynes, A.L.
(74) Freehills Patent & Trade Mark Attorneys
(51)7 A61K 007/48
(10) 782847
(71) Explanar (Holdings) Ltd.
(54) ROOF FLASHING
(10) 782850
(31) PQ5150
(51)7 E04D 013/14
(54) GOLF TRAINING APPARATUS
(31) 500038
(51)7 A63B 069/36
(72) Grigg, G.W.
(74) Blake Dawson Waldron
(31) 0009499
(71) Grunenthal GmbH
(72) Haynes, A.L.
(10) 782862
(72) Blacklock, L.
(74) A J Park
(74) SPRUSON & FERGUSON
(71) Hitachi, Ltd.
(71) F. Hoffmann-La Roche AG
(51)7 C07C 225/00
(10) 782868
(10) 782799
(54) INFORMATION PROCESSING DEVICE,
(54) BRAIN, SPINAL AND NERVE INJURY
INFORMATION PROCESSING METHOD (51)7 A61K 031/405
(72) Putz, C.; Buschmann, H.; Kogel, B.
(51)7 G06K 019/073
(74) SPRUSON & FERGUSON
(31) 2000-079305 (32) 16.03.00
(31) PQ5146
(71) GTC Biotherapeutics, Inc.; Astrazeneca UK
(72) Kaminaga, M.; Endo, T.; Watanabe, T.; Ohki,
Ltd.; Government of the United States of (72) Vink, R.; Nimmo, A.J.
America as represented by the Secretary of (74) Fisher Adams Kelly
(74) Davies Collison Cave
The Department of Health and HumanServices, The (71) Ferag AG
(10) 782840
(71) Ihara Chemical Industry Co., Ltd.
(10) 782812
(10) 782818
(54) TRANSGENICALLY PRODUCED FUSION
(54) METHOD AND DEVICE FOR CHANGING
(54) PROCESS FOR PRODUCING
THE HOLD OF FLAT ARTICLES BEING (51)7 C07H 021/04
SUBSTITUTED ALKYLAMINE DERIVATIVE CONVEYED HELD BY GRIPPERS (51)7 C07D 277/64
(51)7 B65H 029/66
(31) 121/01
(31) 2000-100466 (32) 03.04.00
(72) Gosslinghof, R.
(72) Hijikata, C.
(74) Griffith Hack
(72) Edge, M.D.; Pollock, D.; Echelard, Y.; Meade,
(74) Collison & Co
H.M.; Rybak, S.M.
(74) Davies Collison Cave
(71) Freyssinet International (STUP)
(71) Imperial College Innovations Ltd.
(10) 782827
(10) 782822
(71) H. Lundbeck A/S
(54) ADJUSTABLE ANCHOR BEARING A CIVIL
(10) 782848
(54) CONTROL OF GENE EXPRESSION
ENGINEERING STRUCTURE (51)7 A61K 048/00
(51)7 E01D 019/16
(54) DNA ENCODING SNORF62 AND SNORF72
(31) 9915126
(31) 00 03171
(51)7 C07K 014/72
(72) Buluwela, L.; Ali, S.
(72) Zivanovic, I.; Morisseau, V.
(74) Griffith Hack
(74) Griffith Hack
Genzyme Corp. see Beth Israel Deaconess
(71) Industrial Roll Formers Pty Ltd.
(10) 782823
(72) Bonini, J.A.; Lerman, G.S.; Quan, Y.;
(54) AN ANCHOR DEVICE FOR USE IN MINING
Glaxo Group Ltd. see Laboratoire
Ogozalek, K.
(51)7 E21D 021/00
(74) Davies Collison Cave
(71) Halliburton Energy Services, Inc.
(10) 782865
(72) Fergusson, J.R.
(74) Fraser Old & Sohn
AUSTRALIAN OFFICIAL JOURNAL OF PATENTS 1 September 2005 Applications Accepted - Name Index cont'd
DUAL-DOMAIN OR MULTI-DOMAIN (71) Innomed Technologies, Inc.
(71) Johnson, R.A.
(10) 782824
(10) 782813
(51)7 C12N 015/10
(54) NASAL VENTILATION INTERFACE
(54) LIGHTING TOWER MAST SUPPORT
(51)7 A61M 015/08
(51)7 F21V 021/28
(31) PR1339
(72) Wood, T.J.
(72) Reinl, S.J.; Lindbo, J.A.; Turpen, T.
(74) PIZZEYS
(74) WATERMARK PATENT & TRADEMARK
(72) Johnson, R.A.
Institut National De La Sante Et De La
(74) WRAY & ASSOCIATES
Recherche Medicale - (INSERM) see Aventis
Pharma S.A.

(71) Lexicon Genetics Inc.
(71) Kao Corp.
(10) 782817
(10) 782795
(54) NOVEL HUMAN G PROTEIN COUPLED
(71) Interleukin Genetics, Inc.
(54) DYE COMPOSITION FOR KERATINOUS
RECEPTOR PROTEINS AND (10) 782836
POLYNUCLEOTIDES ENCODING THE (51)7 A61K 007/13
(54) DIAGNOSTICS AND THERAPEUTICS FOR
(31) 2000-074346 (32) 16.03.00
(51)7 C07K 014/705
(51)7 C12Q 001/68
(72) Nakashimada, A.; Fukuhara, M.
(74) PHILLIPS ORMONDE & FITZPATRICK
(72) Donoho, G.; Hilbun, E.
(74) PIZZEYS
(71) Kraft Foods Holdings, Inc.
(72) Kornman, K.S.; Duff, G.W.; Crossman, D.C.;
(10) 782814
Francis, S.E.; Stephenson, K.
(71) Liu, M.; Chen, B.D.F.; Chang, C.P.
(74) Shelston IP
(54) METHOD FOR PREPARING CHEESE
(10) 782810
PRODUCTS AND PROCESS CHEESE (71) International Business Machines Corp.
(51)7 A23C 019/09
(54) DEVICE AND METHOD FOR ABSORBING
(10) 782854
AND RADIATING HEAT IN VERY SMALL SPACE BY ALTERNATELY PUSHING TWO (54) IMPROVEMENTS RELATING TO
GRAPHICAL USER INTERFACES (72) Hyde, M.A.; Carruthers, L.M.; McGeown, J.J.;
(51)7 F25B 041/00
(51)7 G06F 003/14
Trecker, G.W.
(31) 507207
(74) Griffith Hack
(72) Liu, M.; Chen, B.D.F.; Chang, C.P.
(72) Mahoney, J.M.; Bayliss, C.A.
(71) Krasnow Institute
(74) Fraser Old & Sohn
(74) SPRUSON & FERGUSON
(10) 782860
(54) ADAPTIVE ELECTRIC FIELD MODULATION
(71) Mannesmann VDO AG
(71) Johnson & Johnson Consumer Companies,
OF NEURAL SYSTEMS (10) 782849
(51)7 A61N 001/36
(10) 782857
(54) MOTOR VEHICLE NAVIGATION SYSTEM,
METHOD AND STORAGE MEDIUM (54) NOVEL DETERGENT COMPOSITIONS
(51)7 G06F 012/14
WITH ENHANCED DEPOSITING, (31) 00 106810
CONDITIONING AND SOFTNESS (72) Gluckman, B.J.; Schiff, S.J.
(74) PIZZEYS
(51)7 A61K 007/075
(72) Thoone, M.; Drijfhout, T.
(74) Griffith Hack
(71) Laboratoire GlaxoSmithKline S.A.S.;
SmithKline Beecham Corp.; Glaxo Group Ltd.
(72) Niemiec, S.M.; Yeh, H.; Gallagher, R.
(10) 782863
(71) Maritime Pusnes A.S.
(74) Shelston IP
(10) 782845
(54) THE USE OF 5HT4 RECEPTOR
ANTAGONISTS IN THE PROPHYLAXIS OR (54) A ROTATING JACK WINCH
(71) Johnson & Johnson Vision Care, Inc.
TREATMENT OF CERTAIN (51)7 B66D 001/00
(10) 782811
(51)7 A61K 045/08
(54) PROCESS OF MANUFACTURING
CONTACT LENSES WITH MEASURED (72) Hovik, J.; Siring, K.T.
EXPOSURE TO OXYGEN (62) 76529/01
(74) Halford & Co.
(51)7 B29D 011/00
(72) Bonhomme, M.M.J.; Bril, A.M.A.; Gout,
B.E.J.; Patel, B.R.; Shepherd, G.L.
(71) Met-Coil Systems Corp.
(74) Davies Collison Cave
(10) 782829
(72) Caltrider, J.D.; Ricard, J.W.; Spaulding, T.L.;
Steven, J.E.; Calvin, O.W.; Enns, J.B.; (71) Large Scale Biology Corp.
(54) SHEET METAL BENDING APPARATUS
Kindt-Larsen, T.
(10) 782856
(51)7 B21D 005/14
(74) Freehills Patent & Trade Mark Attorneys
(54) CREATION OF VARIABLE LENGTH AND
SEQUENCE LINKER REGIONS FOR AUSTRALIAN OFFICIAL JOURNAL OF PATENTS 1 September 2005 Applications Accepted - Name Index cont'd
(72) Shah, A.; Blum, R.
TETRA-HYDRATE AND DRUG PRODUCT (74) WATERMARK PATENT & TRADEMARK
(72) Schutz, U.
(51)7 A61K 031/195
(74) PHILLIPS ORMONDE & FITZPATRICK
(31) 2000-195852 (32) 29.06.00
(71) Mitsubishi Gas Chemical Co., Inc.
(71) Rochester Gauges, Inc.
(10) 782835
(10) 782859
(54) POLYESTER-BASED RESIN
(54) LIQUID LEVEL GAUGE WITH REMOVABLE
(72) Takada, A.; Sudoh, M.
COMPOSITION AND SHAPED ARTICLES (74) Griffith Hack
(51)7 C08L 067/02
(51)7 G01D 005/18
(31) 2001-060053 (32) 05.03.01
(71) Pharmacia AB
(10) 782796
(72) Takashima, M.; Yamamoto, K.; Nanba, H.
(74) PHILLIPS ORMONDE & FITZPATRICK
(54) PROCESS OF PREPARING TOLTERODINE
(70) Rochester Gauges, Inc.
AND ANALOGUES THERE OF AS WELL AS (72) Ross Jr., H.G.
INTERMEDIATES PREPARED IN THE (74) F B Rice & Co
(71) Mitsubishi Gas Chemical Co., Inc.
(10) 782861
(51)7 C07C 213/02
(71) Rodwell, D.
(10) 782801
(54) SOLID-PHASE DRYING AND SOLID-PHASE
POLYMERIZATION OF POLYAMIDE (54) ANTI-SNORING APPLIANCE
(31) 9904850
(51)7 C08G 069/30
(51)7 A61F 005/56
(31) PQ4752
(72) Andersson, P.G.; Hedberg, C.
(72) Tanaka, K.; Kurose, H.
(74) Davies Collison Cave
(74) PHILLIPS ORMONDE & FITZPATRICK
(72) Wasilewsky, H.; Rodwell, D.
(74) Griffith Hack
(71) Plasticos Vandux De Colombia, S.A.
(71) Nagle, M.J.C.
(10) 782815
(10) 782852
(71) Rohm and Haas Co.
(10) 782834
(54) HAIR BRUSH
(54) CABLE SUPPORTING STAND
(51)7 A46B 005/00
(51)7 F16L 003/02
(54) PIGMENT DISPERSANT COMPOSITION
(31) PR7341
(51)7 C08L 025/08
(72) Bigio, A.L.
(72) Nagle, M.J.C.
(74) Davies Collison Cave
(74) Freehills Patent & Trade Mark Attorneys
(72) Chiou, S.; Egolf, S.L.; Sheng, M.
(74) Davies Collison Cave
(71) Plum Enterprises, Inc.
(71) Newbill, A.J.
Rohm GmbH & Co. KG see BPSI Holdings, Inc.
(10) 782830
(10) 782803
(54) SPARE WHEEL CARRIER
(54) IMPROVED PROTECTIVE HAT
(71) Sahm, J.E.
(51)7 B62D 043/02
(51)7 A42B 003/06
(10) 782842
(54) MULTIFUNCTIONAL APPARATUS FOR
(72) Carrington, J.
THE TREATMENT OF HAIR OF THE HEAD (74) Mallesons Stephen Jaques
(72) Newbill, A.J.
(51)7 A45D 004/18
(74) Davies Collison Cave
(31) 870/00
(71) PolyPlus Battery Co.
(10) 782809
(71) Nojiri, H.
(10) 782855
(72) Sahm, J.E.
(54) LIQUID ELECTROLYTE LITHIUM-SULFUR
(74) PHILLIPS ORMONDE & FITZPATRICK
(54) DOUBLE EYELID FORMING TAPE OR
(51)7 H01M 004/58
SmithKline Beecham Corp. see Laboratoire
STRING AND METHOD OF MANUFACTURING THE SAME (51)7 A61F 009/00
(31) 2000-303797 (32) 03.10.00
(71) St. Elizabeth's Medical Center, Inc.
(72) Katz, B.D.; Chu, M.; Dejonghe, L.C.; Visco,
(10) 782819
(74) Davies Collison Cave
(54) ANGIOGENIC GROWTH FACTORS FOR
(72) Nojiri, H.
TREATMENT OF PERIPHERAL (74) Davies Collison Cave
(71) Protechna S.A.
(10) 782802
(51)7 A61K 038/19
(71) Ono Pharmaceutical Co., Ltd.
(54) FLAP VALVE FOR CONTAINERS AND
(10) 782838
PIPELINES FOR LIQUID (51)7 F16K 003/08
(54) SOLUTION OF N-[O-(P-PIVALOYLOXY
BENZENE SULFONYLAMINO) (72) Isner, J.M.
BENZOYL]GLYCINE MONOSODIUM SALT (74) Davies Collison Cave
AUSTRALIAN OFFICIAL JOURNAL OF PATENTS 1 September 2005 Applications Accepted - Name Index cont'd
Statens Veterinaere Serumlaboratorium see
WITH A PLURALITY OF GATHERS FORMULATIONS FOR USE IN INHALER (51)7 D06C 003/00
(51)7 A61K 009/72
(31) 2001-174866 (32) 08.06.01
(31) 0009468
(71) Stramit Corp. Pty Ltd.
(10) 782808
(72) Ukegawa, K.; Isono, M.; Kamio, H.; Oba, T.
(74) PHILLIPS ORMONDE & FITZPATRICK
(54) PANEL LOCKING ARRANGEMENT
(72) Staniforth, J.N.; Morton, D.A.V.
(51)7 E04D 003/362
(43) 08.08.02
(71) University of Massachusetts
(10) 782846
(71) Wade, R.G.
(62) 52765/98
(10) 782797
(72) Healy, C.L.
(54) GYNOGENETIC OR ANDROGENETIC
(74) PHILLIPS ORMONDE & FITZPATRICK
PRODUCTION OF PLURIPOTENT CELLS (54) FIRST FLUSH RAINWATER DIVERTER
AND CELL LINES, AND USE THEREOF TO AND COLLECTION SYSTEM PRODUCE DIFFERENTIATED CELLS AND (51)7 E03B 003/02
(71) TDY Industries, Inc.
(10) 782864
(51)7 C12N 005/00
(72) Wade, R.G.
(54) CUTTING TOOLS AND DRILL INSERTS
(74) Cullen & Co
WITH CHIP CONTROL GEOMETRY (51)7 B23B 051/02
(71) Worley Pty Ltd.
(10) 782839
(72) Robl, J.M.; Cibelli, J.; Burnside, A.
(74) Davies Collison Cave
(54) A CONNECTION ASSEMBLY
(72) Fang, X.D.; Hartman, T.B.; Wills, D.J.
(51)7 E01B 003/26
(74) Griffith Hack
(71) Vanderbilt University
(31) PR3645
(10) 782853
(71) Tricor Direct, Inc.
(54) METHODS FOR PREVENTING OR
(72) Donohoo, S.M.
(10) 782825
(74) PHILLIPS ORMONDE & FITZPATRICK
(54) MODULAR LINE APPLICATOR
(51)7 A61K 039/09
(51)7 E01C 023/24
(71) Wyeth
(10) 782867
(54) ANTHELMINTIC COMPOSITION
(72) Bound, K.R.
(51)7 A61K 031/7048
(62) 51257/99
(74) PIZZEYS
(31) 507445
(72) Hellerqvist, C.G.
(74) F.B. Rice & Co.
(71) Uni-Charm Corp.
(10) 782804
(71) Vectura Ltd.
(72) Jancys, A.H.
(10) 782841
(74) Shelston IP
(54) STRETCHABLE COMPOSITE SHEET AND
PROCESS FOR FORMING THE SAME (54) IMPROVEMENTS IN OR RELATING TO
Plasticos Vandux De Colombia, S.A.
Bridge Pharma, Inc.
Lexicon Genetics Inc.
Computer Controlled Syringe Inc.
Ihara Chemical Industry Co., Ltd.
F. Hoffmann-La Roche AG St. Elizabeth's Medical Center, Inc.
Protechna S.A.
Imperial College Innovations Ltd.
Newbill, A.J.
Industrial Roll Formers Pty Ltd.
Uni-Charm Corp.
Innomed Technologies, Inc.
Aberdeen University Statens Veterinaere Tricor Direct, Inc.
Can-Fite Biopharma Ltd.
Ethicon, Inc.
Freyssinet International (STUP) Beth Israel Deaconess Medical Center Genzyme Corp.
BPSI Holdings, Inc. Rohm GmbH & Co. KG Stramit Corp. Pty Ltd.
Met-Coil Systems Corp.
PolyPlus Battery Co.
Plum Enterprises, Inc.
Liu, M. Chen, B.D.F. and Chang, C.P.
Chemgen Corp.
Johnson & Johnson Vision Care, Inc.
Electronic Finger Print Technologies Ltd.
Aventis Pharma S.A. Institut National De La Sante Et De Johnson, R.A.
La Recherche Medicale - (INSERM) Kraft Foods Holdings, Inc.
Rohm and Haas Co.
AUSTRALIAN OFFICIAL JOURNAL OF PATENTS 1 September 2005 Applications Accepted - Numerical Index cont'd
Mitsubishi Gas Chemical Co., Inc.
D. Swarovski & Co Interleukin Genetics, Inc.
Nagle, M.J.C.
Ciba Specialty Chemicals Holding Inc.
Vanderbilt University Ono Pharmaceutical Co., Ltd.
International Business Machines Corp.
Worley Pty Ltd.
GTC Biotherapeutics, Inc. Astrazeneca UK Ltd. and Large Scale Biology Corp.
Government of the United States of America as Johnson & Johnson Consumer Companies, Inc.
represented by the Secretary of The Department of Chiron Corp.
Health and Human Services, The Rochester Gauges, Inc.
Vectura Ltd.
Krasnow Institute Mitsubishi Gas Chemical Co., Inc.
Basf Aktiengesellschaft Laboratoire GlaxoSmithKline S.A.S. SmithKline Beecham Maritime Pusnes A.S.
Corp. and Glaxo Group Ltd.
University of Massachusetts TDY Industries, Inc.
Haynes, A.L.
Halliburton Energy Services, Inc.
Mannesmann VDO AG Explanar (Holdings) Ltd.
Hitachi, Ltd.
IPC Index
A01K 067/-
A46B 005/-
A61P 009/-
B21D 005/-
C07C 035/-
A61K 033/-
A01N 037/-
A46B 009/-
B21D 037/-
C07C 049/-
A61P 017/-
A61K 038/-
A01N 043/-
A61B 017/-
B21D 053/-
C07C 213/-
A61P 025/-
A01N 047/-
A61K 039/-
B23B 051/-
C07C 215/-
A61F 002/-
A61P 031/-
A01N 057/-
B29C 039/-
C07C 217/-
A61F 005/-
A61K 045/-
A61P 033/-
A01N 061/-
B29D 011/-
C07C 225/-
A61F 009/-
A61K 047/-
A61P 035/-
A23C 019/-
B60Q 001/-
C07C 251/-
A61F 013/-
A61K 048/-
A42B 003/-
A61P 037/-
B62D 043/-
C07D 235/-
A61K 007/-
A45D 004/-
A61M 005/-
B65D 001/-
C07D 237/-
A61P 039/-
A61K 009/-
A45D 020/-
A61M 015/-
B65D 047/-
C07D 241/-
A61P 043/-
A45D 040/-
A61K 031/-
A61N 001/-
B65H 029/-
C07D 277/-
A63B 069/-
A45D 044/-
A61P 003/-
B66D 001/-
B05D 003/-
C07D 307/-
AUSTRALIAN OFFICIAL JOURNAL OF PATENTS 1 September 2005 Applications Accepted - IPC Index cont'd
C07D 311/-
C07H 021/-
C09C 003/-
E01D 019/-
F16L 003/-
G06F 017/-
C07D 333/-
C09D 011/-
E01F 009/-
F21V 021/-
C07K 001/-
G06K 019/-
C07D 401/-
C12N 001/-
E03B 003/-
F25B 041/-
C07K 014/-
G07F 007/-
C12N 005/-
E04D 003/-
F25B 049/-
C07D 403/-
G07F 019/-
C12N 015/-
E04D 013/-
G01D 005/-
C07D 409/-
C07K 016/-
G08G 001/-
E04H 012/-
G01D 013/-
C07D 417/-
C08F 002/-
G12B 011/-
C12P 021/-
E21B 043/-
G01F 023/-
C07D 487/-
C08G 069/-
H01M 004/-
E21D 021/-
G01N 033/-
C07D 491/-
C08K 005/-
C12Q 001/-
H01M 006/-
F16K 003/-
G03F 007/-
C07D 495/-
H02G 001/-
C08L 023/-
D06C 003/-
F16K 011/-
G06F 003/-
H02G 003/-
C07D 498/-
C08L 025/-
E01B 003/-
F16K 031/-
G06F 012/-
H05K 007/-
C07D 513/-
C08L 067/-
E01C 023/-
Solvay Pharmaceuticals GmbH (Thorgard
Pharmaceuticals (Aust.) Pty Ltd) (The name in the parentheses is that of the opponent) Famco Lighting Pty. Ltd. (Thomas & Betts (Australasia)
Osram Sylvania Inc. (BHP Billiton SSM Development Pty
WMS Gaming Inc. (Aristocrat Technologies Australia Pty
Imperial Chemical Industries PLC (E.I. DU PONT DE
WMS Gaming Inc. (Aristocrat Technologies Australia Pty
NEMOURS AND COMPANY) GS Technology Pty Ltd (Brisbane City Council)
Acres Gaming, Inc. (Aristocrat Technologies Australia
GS Technology Pty Ltd (Brisbane City Council)
Unilin Beheer B.V. (Kronotex-Fussboden GmbH)
Opposition under Section 104(4) - Withdrawn
Unilin Beheer B.V. (Kronotex-Fussboden GmbH)
AUSTRALIAN OFFICIAL JOURNAL OF PATENTS 1 September 2005 Letters Patent Sealed
Assignments Registered - cont'd
692815 Scophysa The patent has been assigned to Ferring B.V.
698248 Kazuhiro Matsuda The patent has been assigned to M
Bio Technology, Inc.
712814 Biochemie Gesellschaft m.b.H. The patent has been
assigned to Sandoz AG
714017 Biochemie Gesellschaft mbH The patent has been assigned to Sandoz AG
715682 Biochemie Gesellschaft m.b.H. The patent has been
assigned to Sandoz AG
717292 Syngenta Participations AG The patent has been assigned to Sandoz AG
718653 Formosa Electronic Industries Inc The patent has been
assigned to Golden Bridge Electech Inc.
718818 Terrence James Parke The patent has been assigned to Bearcorp Pty Ltd
722858 C-Chem AG The patent has been assigned to Scynexis,
Inc.

723925 Thermo-Med 2000 KFT The patent has been assigned to
INVATEC S.r.l.
633541 Solomon B. Margolin The patent has been assigned to 724774 Grove U.S. LLC. The patent has been assigned to JLG
MARNAC, Inc.; KDL GmbH
637317 Biochemie Gesellschaft m.b.H. The patent has been 732845 Minister of Agriculture Fisheries and Food in Her Britannic assigned to Sandoz AG
Majesty's Government of the United Kingdom of Great Britain and
Northern Ireland, The The patent has been assigned to University
638784 Biochemie Gesellschaft M.B.H. The patent has been of Warwick
assigned to Sandoz AG
734897 Biochemie Gesellschaft MBH The patent has been 648369 Biochemie Gesellschaft mbH The patent has been assigned to Sandoz AG
assigned to Sandoz AG
734953 Pharming B.V.; Erasmus Universiteit Rotterdam; Academic 659282 Biochemie Gesellschaft m.b.H. The patent has been Hospital Rotterdam The patent has been assigned to Genzyme
assigned to Sandoz AG
Corporation; Erasmus Universiteit Rotterdam; Erasmus MC
671483 John Murray Bowers; Scott Murray Bowers The patent 735188 Biochemie Gesellschaft MBH The patent has been has been assigned to Rota-Tech Dairy Sheds International
assigned to Sandoz AG
742856 PVAXX Technologies Limited The patent has been 671792 John Murray Bowers The patent has been assigned to assigned to PVAXX Research and Development Limited
Rota-Tech Dairy Sheds International Limited
744955 John Murray Bowers The patent has been assigned to 674637 John Murray Bowers The patent has been assigned to Rota-Tech Dairy Sheds International Limited
Rota-Tech Dairy Sheds International Limited
745988 FFHK Development Company LLC The patent has been 679599 Starlabo Corporation The patent has been assigned to assigned to Francis Y. Falck; Robert W. Falck
Leica Geosystems GIS & Mapping, LLC
749735 Biochemie Gesellschaft mbH The patent has been 686380 Biochemie Gesellschaft mbH The patent has been assigned to Sandoz AG
assigned to Sandoz AG
749811 Terrence James Parke The patent has been assigned to 690108 Dial-A-Box Pty Ltd The patent has been assigned to Bearcorp Pty Ltd
Molcar Pty Ltd
757799 Biochemie Gesellschaft m.b.H. The patent has been 691133 Kabushiki Kaisha Sekuto Kagaku The patent has been assigned to Sandoz AG
assigned to Suikoh Topline Co., Ltd
759517 Biochemie Gesellschaft M.B.H. The patent has been 691517 Kabushiki Kaisha Sekuto Kagaku The patent has been assigned to Sandoz AG
assigned to Suikoh Topline Co., Ltd
AUSTRALIAN OFFICIAL JOURNAL OF PATENTS 1 September 2005 Assignments Registered - cont'd
Extensions of Term of Standard Patents, Section 70
759932 FFHK Development Company LLC The patent has been assigned to Francis Y. Falck; Robert W. Falck
The following application(s) for Extension of Term under Section 70 759951 FFHK Development Company LLC The patent has been have been filed.
assigned to Francis Y. Falck; Robert W. Falck
760168 C-Chem AG The patent has been assigned to Scynexis,
624022 Les Laboratoires Servier
PROTOS strontium ranelate 763743 PVAXX Technologies Limited The patent has been
assigned to PVAXX Research and Development Limited
768134 Thermo-Med 2000 KFT The patent has been assigned to In Vol 19, No 26, Page(s) 448 under the heading Applications
Accepted - Name Index in the name of F. Hoffman-La Roche AG,
Serial no. 782191, INID (71), amend the applicant to read F.
Hoffmann-La Roche AG
775107 Grandis Biotech GmbH The patent has been assigned to
Sandoz AG
775662 Biochemie Gesellschaft mbH The patent has been
assigned to Sandoz AG
The following specifications contained errors when advertised OPI orAccepted. They have been reissued on the AU-A or AU-B CD-ROM 775681 Biochemie Gesellschaft mbH The patent has been of this Journal date.
assigned to Sandoz AG
782191 F Hoffmann-La Roche AG
776416 HT Troplast AG The patent has been assigned to
Kuraray Specialities Europe GmbH
782445 McNeil-PPC, Inc.
776662 Biochemie Gesellschaft mbH The patent has been
assigned to Sandoz AG
777055 Airlight Limited (AG) The patent has been assigned to
Prospective Concepts AG
778167 Pharming BV; Erasmus Universiteit Rotterdam; Academic
Hospital Rotterdam The patent has been assigned to Genzyme
Corporation; Erasmus Universiteit Rotterdam; Erasmus MC

779525 HT Troplast AG The patent has been assigned to
Kuraray Specialities Europe GmbH
(The name in parentheses is that of the licensee) 777864 Hertel, R. (Joker AG/SA)
654287 Laser Design International LLC (Crystal Concepts
Holdings Pty Ltd)
(The name in the parentheses is that of the mortgagee) 777564 Amylin Pharmaceuticals, Inc. (Eli Lilly and Co.)
  • not pat jnl v19_34.pdf

    Source: https://www.ipaustralia.gov.au/sites/g/files/net856/f/journals/19_34.pdf

    radiologie-mim.fr

    Vous allez passer une ponction-biopsie hépatique sous échographie Il est normal que vous vous posiez des questions sur l'examen que vous allez être amené à passer. Vous trouverez ci-dessous un certain nombre d'informations sur cet examen et son déroulement. Si toutefois vous ne trouvez pas toutes les réponses à vos questions, n'hésitez pas à nous interroger à nouveau pour tout renseignement complémentaire.

    Microsoft word - caprio - aproximaciones para una antropología analítico 20–

    para una antropología Lic. Graciela Caprio Dr. Alfried Längle CIANAE - CENTRO de INVESTIGACIÓN de ANTROPOLOGÍA ANALÍTICO-EXISTENCIAL Av. Belgrano 319 Piso 3º "7", Buenos Aires, Argentina – CP 1092AAD – Tel: 4343--7692 www.cianae.org.ar – e-mail : ciana_e@yahoo.com.ar Aproximaciones para una antropología analítico-existencial